News and Views
Nature Genetics 40, 131 - 132 (2008)
doi:10.1038/ng0208-131
The developing mosaic of autoimmune disease risk
Lisa M Maier1 & David A Hafler1
- Lisa M. Maier and David A. Hafler are in the Division of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, 77 Ave. Louis Pasteur NRB 641, Boston, MA 02115 and at the Broad Institute of Harvard University and Massachusetts Institute of Technology. e-mail: hafler@broad.mit.edu
Abstract
The discovery of new risk variants for systemic lupus erythematosis (SLE), particularly around lymphocyte signaling pathways and integrins involved in clearing complement, provides fresh insights into this common human autoimmune disease. Understanding the role of the variants in disease pathophysiology and translating these findings into new therapies present major and urgent challenges to medical scientists.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Genetic studies of systemic lupus erythematosus in Asia: where are we now?Genes and Immunity Original Article
Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj???gren's syndromeGenes and Immunity Original Article
A lupus-susceptibility C57BL/6 locus on chromosome 3 (Sle18) contributes to autoantibody production in 129 miceGenes and Immunity Original Article
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusNature Genetics Letter (01 Nov 2009)
See all 13 matches for Research
